Imba - Dissertation
Nyanzvi yechokwadi yekunyora yeChinhizheni yeChincher Cancer neIvha Banife & ImunOprerapy: Umipic, inogona kukwana kuvhiya kwakawanda, chemotherapy uye radiation kurapwa kwematanho ese echikepe chakasimba chebunako rwakasimba
Drug yakasanganiswa neH2 O2 jekiseni intratuniaral kutendeuka iyo yekuwedzera matrix mune autologius coagulum sekudhaka depot
Tariro Itsva yeChinhizheni yekurapa ine mvura yekoni & immuno kurapwa: Umipic
Acute tumor Faclammation ine CD4 / 8 + uye CD11 + Yakavandudzwa Nguva Yakapona Nguva Inosvika Matanho Ekupedzisira Kwese Incisional Inction Yakasarudzika ChemoMunoterrapy
Kuzvimba kwakakosha neanosarudzika kutaura kweCD11 & CD4 inoburitsa iyo Abscalal maitiro neIntraMory Injekiseni Chemotherapy Dhaka neHapten Muenzaniso Wemhando
Nguva itsva yeLmmuno kuvhiya iri kuuya: Iyo isingagumi nzira yekunyora yekunyora neyemvura ine mvura banga & lmmuno kurapwa
Acute tumor faclammation ine CD4 / 8 + uye CD11 + inowedzera muitiro wekupukunyuka uchisanganiswa nemishonga yemishonga yechipesa ne hydrapine seHapten mumhando yemhuka
Kumutsa immune masero naHapten yakagadziridzwa intrumoral chemotherapy ne penicillin prelong cancer kupukuta
Kubudirira Kunovharirwa MuSt Yenzvimbo Oncogenic Qeilar Antigen naHapten Yakamisikidzwa Tumor Yakabatana Autantiboes (Itaaa)
Iyo yekushanduka shanduko inokonzerwa ne intratumoral Hapten Plus Chemotherapy Zvinodhaka zveEndometrialcancancer
Cancer immunothrapy kugadzirira uye immune masero masero activation kuburikidza neTapen-yakagadziridzwa chemotherapy muPrimary Lung Cancer
Chemical immune decation yePrecalusus Cervical Lessions Inomutsa immune masero uye inodzosera yakajairika HPV isina kunaka uye isina kujairika kuwedzera
Mhedzisiro yeSodium Stiboglucon
Shandisa SCRNA-SEQ Profile Kuti Udzorere ImpunOlogic Mhinduro Mushure meIntra-Tumor Hapen Cemoterapy Hemoterapy Hemangial Anaplastic HemangopericyToma Lever Metastasis: Chinyorwa Chemusoro
Hapten-Yakareverwa Chemical Immely Incerapy neVanoita Dhongi muCervical Cancer pasina Hystelerectomy: kumutsa immune masero ekudzivirira kuti immunomtherapy
Biomarker kuwanikwa muHepatocellular carcinoma (HCC) yekumanikidza uye yakawedzera prognosis